Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal...
Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to our newsletter for direct...
Company exits stealth to launch molecular gates
On this week’s podcast we have a conversation with Jordi Mata-Fink, co-founder and chief executive officer of Gate Bioscience. Gate Bioscience is a U.S.-based biotechnology company creating a new class of medicines called Molecular...
‘Strange metal’ is strangely quiet in noise experiment
HOUSTON – (Nov. 23, 2023) – True to form, a “strange metal” quantum material proved strangely quiet in recent quantum noise experiments at Rice University. Published this week in Science, the measurements of quantum...
Separating out signals recorded at the seafloor
Blame it on plate tectonics. The deep ocean is never preserved, but instead is lost to time as the seafloor is subducted. Geologists are mostly left with shallower rocks from closer to the shoreline...
AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to...
Cell Signaling Technology (CST), a life science biotechnology company and leading provider of antibodies, kits, and services, and Amoy Diagnostics Co., Ltd. (AmoyDx), a China-based innovative molecular diagnostics company in the field of precision oncology,...
The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy
Immunotherapy has revolutionized cancer treatment, offering promising avenues beyond traditional methods. Recent breakthroughs showcased at the Society for Immunotherapy of Cancer’s (SITC) annual meeting have spotlighted innovative approaches, notably chimeric antigen receptor macrophage (CAR-M)...
How tiger teams are transforming the life sciences startup landscape
The life sciences ecosystem is facing a critical moment of transformation, driven by a new generation of startups that adopt a novel approach to scaling up. Unwilling to conform to the status quo, these...
Drones enabled the use of defibrillators before ambulance arrival
Researchers at Karolinska Institutet have evaluated the possibility of alerting drones equipped with automated external defibrillators (AED) to patients with suspected cardiac arrest. In more than half of the cases, the drones were ahead...
Repurposed drugs hold promise for targeting cancer stem cells
In a review published in the journal Genes & Diseases, researchers from ICMR-National Institute of Nutrition (NIN), advocate for the repurposing of non-cancer drugs to target these elusive CSCs. By focusing on drugs that...
Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment
Until the approval of Apellis’ Syfovre earlier this year, there was no treatment for geographic atrophy. Shortly after, Astellas’ Izervay was also approved for the eye condition. Now, as the only two companies with...
